Angiodynamics ANGO
NASDAQ ANGO
$15.08 -0.24 (-1.57%)
As of: Sep 10, 2026 · 2:10 PM EDT

Angiodynamics (ANGO) Receivables - Other (2012)

Angiodynamics' (ANGO) quarterly Receivables - Other came in at $2.5 million in Q4 2012, little changed quarter-over-quarter from $2.5 million in Q3 2012.

Analysis

Angiodynamics (ANGO) Receivables - Other (2012) Analysis & Trends

Angiodynamics (ANGO) has reported Receivables - Other for 1 consecutive years, with $2.5 million the latest figure, recorded in Q4 2012.

  • For the quarter ending Q4 2012, Receivables - Other changed N/A year-over-year to $2.5 million; the trailing twelve-month figure through Nov 2012 stood at $2.5 million (changed N/A YoY), and the FY2012 full-year result was $2.5 million, changed N/A from the prior year.
  • Receivables - Other was little changed at $2.5 million in Q4 2012 per ANGO's latest filing, from $2.5 million in the prior quarter.
  • Across five years, Receivables - Other topped out at $2.5 million in Q2 2012 and bottomed at $2.5 million in Q2 2012.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 180.69 Bn 175.09 Bn 7.27 Bn
2 Intuitive Surgical 127.23 Bn 122.02 Bn 1.96 Bn
3 Medtronic 116.90 Bn 108.08 Bn 6.34 Bn
4 Stryker 103.91 Bn 100.43 Bn 4.50 Bn
5 Boston Scientific 63.54 Bn 63.00 Bn 3.85 Bn
6 Edwards Lifesciences 49.74 Bn 45.49 Bn 1.35 Bn
7 Alcon 32.96 Bn 31.51 Bn 1.68 Bn
8 Dexcom 32.02 Bn 30.07 Bn 830.00 Mn
9 Steris 20.70 Bn 20.21 Bn 684.20 Mn
10 Angiodynamics 626.21 Mn 572.35 Mn 46.77 Mn
Historic Data

Historic Data

Download Data
DateValue
Nov 30, 2012 2.50 Mn
Aug 31, 2012 2.50 Mn
May 31, 2012 2.50 Mn